A revolutionary approach to cancer therapy. Single tablet regimens for HIV. A cure for hepatitis C.
For more than 30 years, Gilead’s research program has achieved advancements that were once thought impossible. As we bring new products into clinical development, our goal remains the same – to discover, develop and commercialize therapeutics that transform care for people around the world.
Our research and development programs currently focus on potential treatments in HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.
Some of the content on this page is not intended for users outside the US.